Free Trial

RXO (NYSE:RXO) Price Target Cut to $24.00 by Analysts at The Goldman Sachs Group

RXO logo with Transportation background

RXO (NYSE:RXO - Free Report) had its price target reduced by The Goldman Sachs Group from $28.00 to $24.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

A number of other equities research analysts have also recently commented on RXO. Susquehanna lowered their target price on RXO from $16.00 to $12.00 and set a "negative" rating on the stock in a research note on Tuesday, November 12th. Benchmark reissued a "hold" rating on shares of RXO in a research report on Wednesday, January 15th. Stifel Nicolaus cut their price target on RXO from $27.00 to $24.00 and set a "hold" rating for the company in a research note on Thursday. Jefferies Financial Group lowered their price objective on RXO from $33.00 to $30.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Finally, Citigroup lowered shares of RXO from a "buy" rating to a "neutral" rating and set a $33.00 target price for the company. in a research report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $26.46.

Check Out Our Latest Stock Report on RXO

RXO Stock Up 4.8 %

RXO traded up $0.99 during mid-day trading on Thursday, reaching $21.50. 1,456,578 shares of the stock were exchanged, compared to its average volume of 1,176,434. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.33 and a current ratio of 1.26. The company has a 50 day moving average price of $25.42 and a two-hundred day moving average price of $27.35. RXO has a 1 year low of $18.75 and a 1 year high of $32.82. The stock has a market capitalization of $3.46 billion, a PE ratio of -10.14, a price-to-earnings-growth ratio of 3.63 and a beta of 1.53.

RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. As a group, research analysts anticipate that RXO will post 0.39 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Cibc World Markets Corp bought a new stake in RXO in the 4th quarter worth approximately $356,000. Royce & Associates LP lifted its holdings in shares of RXO by 32.5% in the 4th quarter. Royce & Associates LP now owns 53,000 shares of the company's stock worth $1,264,000 after acquiring an additional 13,000 shares during the last quarter. Natixis Advisors LLC boosted its stake in shares of RXO by 18.1% in the 4th quarter. Natixis Advisors LLC now owns 506,570 shares of the company's stock valued at $12,077,000 after purchasing an additional 77,582 shares in the last quarter. First Eagle Investment Management LLC grew its holdings in shares of RXO by 18.8% during the 4th quarter. First Eagle Investment Management LLC now owns 340,875 shares of the company's stock valued at $8,126,000 after purchasing an additional 54,000 shares during the last quarter. Finally, Swiss National Bank lifted its stake in RXO by 0.6% in the fourth quarter. Swiss National Bank now owns 201,800 shares of the company's stock worth $4,811,000 after purchasing an additional 1,200 shares during the last quarter. Institutional investors own 92.73% of the company's stock.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

See Also

Analyst Recommendations for RXO (NYSE:RXO)

Should You Invest $1,000 in RXO Right Now?

Before you consider RXO, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.

While RXO currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines